BlueRock Therapeutics Compagnie réclamée
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Lire la suite
The LTI program is quite robust.
Qu’est-ce qui vous rend le plus heureux au travail?
I work with a very talented group of people who I love learning from.
Quelles sont les meilleures choses à propos de votre équipe?
Everyone on my team genuinely cares about each other and is very supportive, whether it be personal or work related.
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
The leaders at BlueRock are authentic in the way they talk about their work and in their delivery of that work.
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
We are working on challenging things with a group of people who are passionate and excited to make a difference in patients lives.
Other Employee Reviews for BlueRock Therapeutics
×